|
Volumn 8, Issue 1, 2005, Pages 1-2
|
Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN E4;
BLOOD CLOTTING FACTOR 5 LEIDEN;
ESTRADIOL;
ESTROGEN RECEPTOR;
GESTAGEN;
ALCOHOL ABSTINENCE;
BONE DENSITY;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR EFFECT;
DEMENTIA;
DNA MICROARRAY;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
ENDOMETRIUM;
FEMALE;
GENETIC PREDISPOSITION;
HORMONE SUBSTITUTION;
HUMAN;
LOW DRUG DOSE;
MENOPAUSAL SYNDROME;
POSTMENOPAUSE OSTEOPOROSIS;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SECONDARY PREVENTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
TABLET;
THROMBOEMBOLISM;
VAGINA RING;
ADULT;
DECISION MAKING;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
MENOPAUSE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 18744412355
PISSN: 13697137
EISSN: None
Source Type: Journal
DOI: 10.1080/13697130500042292 Document Type: Editorial |
Times cited : (6)
|
References (10)
|